Learning Objectives 

  • Define risk factors and epidemiological risk factors associated with intrahepatic cholangiocarcinoma
  • Outline the surgical approach to operative management of intrahepatic cholangiocarcinoma
  • Characterize imaging characteristics and staging of intrahepatic cholangiocarcinoma
  • Explain the incidence of recurrence and role of systemic therapy for intrahepatic cholangiocarcinoma

Session Faculty:
Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, FACS, FSSO, FRACS (Hon.), has no relevant financial relationships to disclose. 

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial products.

 

Session date: 
12/09/2022 - 8:00am to 9:00am EST
Location: 
Boston University School of Medicine
United States
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.